- Home
- MBNKP vs CMMB Comparison
MBNKP vs CMMB Comparison
Compare MBNKP & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBNKP
- CMMB
- Stock Information
- Founded
- MBNKP N/A
- CMMB 2004
- Country
- MBNKP United States
- CMMB Israel
- Employees
- MBNKP 128
- CMMB N/A
- Industry
- MBNKP Commercial Banks
- CMMB Biotechnology: Pharmaceutical Preparations
- Sector
- MBNKP Finance
- CMMB Health Care
- Exchange
- MBNKP Nasdaq
- CMMB Nasdaq
- Market Cap
- MBNKP N/A
- CMMB 23.6M
- IPO Year
- MBNKP 2019
- CMMB N/A
- Fundamental
- Price
- MBNKP $25.53
- CMMB $1.39
- Analyst Decision
- MBNKP
- CMMB Strong Buy
- Analyst Count
- MBNKP 0
- CMMB 2
- Target Price
- MBNKP N/A
- CMMB $9.00
- AVG Volume (30 Days)
- MBNKP N/A
- CMMB 863.6K
- Earning Date
- MBNKP N/A
- CMMB 03-03-2025
- Dividend Yield
- MBNKP N/A
- CMMB N/A
- EPS Growth
- MBNKP N/A
- CMMB N/A
- EPS
- MBNKP N/A
- CMMB N/A
- Revenue
- MBNKP N/A
- CMMB N/A
- Revenue This Year
- MBNKP N/A
- CMMB N/A
- Revenue Next Year
- MBNKP N/A
- CMMB N/A
- P/E Ratio
- MBNKP N/A
- CMMB N/A
- Revenue Growth
- MBNKP N/A
- CMMB N/A
- 52 Week Low
- MBNKP N/A
- CMMB $0.58
- 52 Week High
- MBNKP N/A
- CMMB $2.55
- Technical
- Relative Strength Index (RSI)
- MBNKP 52.43
- CMMB 38.56
- Support Level
- MBNKP $25.30
- CMMB $1.21
- Resistance Level
- MBNKP $25.79
- CMMB $1.54
- Average True Range (ATR)
- MBNKP 0.10
- CMMB 0.16
- MACD
- MBNKP 0.03
- CMMB -0.01
- Stochastic Oscillator
- MBNKP 51.15
- CMMB 32.73
About MBNKP Medallion Bank Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series F
Medallion Bank is engaged in providing consumer loans, raising deposits, and manages other banking activities. It offers affordable financing for home improvement contractors, including window, siding, and roof replacements, kitchen, bath and basement remodels, HVAC (Heating Ventilation and Air Conditioning), and solar PV installations. Medallion also offers recreation financing for new and used motorhomes, towable RVs, truck campers, cargo trailers, utility trailers, horse trailers, and a variety of ATVs and other power sport vehicles. Its segments are Recreation; Home Improvement; and Other. The company generates maximum revenue from the Recreation segment.
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.